Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials
Scott M. Nelson(Western Infirmary), Joan‐Carles Arce(Ferring Pharmaceuticals (Denmark))
Cited by 134
Related Papers
Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response
|Human Reproduction Update|2014|258
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
|Human Reproduction Update|2023|117
A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II)
|Annals of Clinical Biochemistry International Journal of Laboratory Medicine|2011|112
The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
|Human Reproduction|2012|94
Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women
|Fertility and Sterility|2023|20